This round is no longer accepting investments, but hundreds just like it are live now.

CLOSED

GET A PIECE OF MEDANSWERS

Innovative Infertility App

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

REASONS TO INVEST

ABOUT

HEADQUARTERS

WEBSITE
View Site

TEAM

Alice Crisci
Alice Crisci
Chief Executive Officer
Alice Crisci is a cancer survivor, entrepreneur, author and activist. She founded Ovum Medical as a science and technology company to solve health care problems through technology. Their first product MedAnswers helps infertile people in crisis connect with the specialist they need. She also founded the oncofertility charity, Fertile Action, three weeks into her breast cancer diagnosis at 31-years-old. She published her first book, "Too Young for This," a few days before her double mastectomy. As Director of Government Affairs and Patient Advocacy for the California Cryobank, a reproductive tissue bank, from 2012 - 2015, Ms. Crisci established regulatory relationships across multiple sectors and within both the US Congress and California Legislature. Her firm, Ovum Medical, is the only group tracking legislation for gamete banks across the country. Ms. Crisci also co-built a revenue acceleration consulting firm in her 20's that sold to the oldest direct selling company in the nation. Her subsequent consulting company called Beeline Global, accelerated growth for start-ups and companies between $10 and $25M in revenue but was sidelined by her cancer diagnosis. She is currently a strategic advisor to other start-ups in the health tech space including oncology companies, genomics ventures and educational institutions. She is the ecstatic mom of a fertility preservation miracle son who at three-years-old calls himself a scientist and the future owner of MedAnswers. Aptly named Dante, meaning enduring, they reside in Southern California with their stray cat named Josh and Shih Tzy Nay-Nay. Ms. Crisci has been featured in major publications across the world and on national television shows like The Doctors and The Today Show.
Santiago Munne, PhD
Santiago Munne, PhD
Scientific Co-Founder
Dr. Santiago Munné, Ph.D is a reproductive geneticist who developed the first Preimplantation Genetic Diagnosis (PGD) test to detect embryonic numerical chromosome abnormalities to avoid Down’s syndrome and other abnormalities. He co-founded Reprogenetics in 2000 to expand PGD services to Europe, Japan and South America. His team has performed over 80,000 PGD cycles for chromosome abnormalities to improve IVF outcomes with over 300 research publications. He is a frequent lecturer, both nationally and internationally, on his team's work in the field of Preimplantation Genetics. He exited Reprogenetics US and UK, a company as CEO in 2016 when he sold to CooperSurgical. He also co-founded Recombine, a reproductive genetics company for carrier screening and a breakthrough genetic test called FertilityMap in 2014, which he sold to CooperSurgical for $85M in 2016. He co-founded the spinout of Recombine, Phosphorus, a computational genomics venture, in August, 2016. Dr. Munne is currently CSO of CooperGenomics and co-founder of MedAnswers. Originally from Barcelona, Dr. Munné gained his Ph.D. in genetics from the University of Pittsburgh. He is also the proud father of two daughters.
Carter Freeman

Carter Freeman

Consulting CFO

An accomplished professional with over 25 years of senior-level financial and accounting experience, Carter has demonstrated an ability to embrace new situations, establish trust and develop a workable game plan. Carter's capabilities encompass negotiating ownership transition leading and supporting capital raising efforts totaling over $100 million, participating in multiple acquisitions from both the buy- and sell-side, in addition to merging operations as acquirer and acquiree.
Sebastian Castillo

Sebastian Castillo

CTO

Sebastian Castillo is a computer scientist with a background in systems engineering and dynamic languages. He was responsible for paymentez. He led growth from zero to 1.3M active users and 1.2k hits per second; and $0 to $300m. He was responsible development (Java) and backend (python) for Colombia's largest ISP; lead for the health care payments system for all of Colombia, with 32 Linux servers including firewall, db, load balancer deployments, and led security of Bancolombia using Sabsa.
David Alzate

David Alzate

VP, Technology

David holds a degree in System Engineering from EAFIT, and also a Master degree in Entrepreneurship and Innovation Management from KTH (Sweden). David is an ardent proponent and teacher of the Lean Startup methodology and SCRUM. He recently launched his first iOS app (servirank) using Apple's new programming language (Swift), as a personal project. David has lived and worked in the US, Colombia, India and Sweden, and excels at managing multicultural environments.
Lori Sanford

Lori Sanford

Consulting Senior Controller

Lori is a seasoned finance and operations executive with more than 30 years of finance, accounting and operational experience. Particular strengths include M&A, due diligence and audit support, software implementation and conversions, and the establishment of financial and business policies and best practices. She also assists us with funding acquisition, investor relations, budgets and forecasts, corporate governance, process reengineering and other complex accounting issues.
Catherine Welch, MBA

Catherine Welch, MBA

Dir. Expert Engagement - US

Catherine Welch is an accomplished clinical embryologist with over 14 years of experience in the IVF field. She is dedicated to reproductive genetics, specifically preimplantation genetic testing and carrier screening technologies. She has participated as an speaker instructor for many of Illumina’s KOL summits and trophectoderm biopsy workshops and Catherine lives in Southern California with her husband and four children.
Demián Glujovsky, MD

Demián Glujovsky, MD

Dir. Expert Engagement - LATAM

Dr. Demián Glujovsky is an internationally renowned specialist in reproductive medicine, overseeing Latin American expansion. Since 2005, he is part of the medical staff at CEGYR, Buenos Aires, Argentina. Dr. Glujovsky has been trained in two recognized reproductive centers in the United States: Reproductive Medicine Associates (RMA) of NJ and the Center for Women’s Reproductive Care at Columbia University in NYC.
Katherine Wu

Katherine Wu

Dir. Regulatory Affairs

Katherine Wu oversees the regulatory path for the groundbreaking app, MedAnswers in the US, Latin America and Europe. Katherine holds a BS in Molecular, Cell, and Developmental Biology and a minor in Political Science from UCLA and has worked with patients, doctors, researchers and scientists to help deepen the knowledge and broaden our understanding on some of the world's most prevalent diseases.
Sebastian Arcila

Sebastian Arcila

Engineer

Sebastian Arcila is a multiple winner of ACM-ICPC challenges. He recently left CECI at MIT in Cambridge, and also has degrees from EAFIT, in Systems engineering, Math, Algorithms, and Data Structures. Most recently, he was one of the first engineers at WeHeartIt where he scaled the application to 25m users. Previously, he was a lead engineer at numerous well-known startups: Authy, TopTal, Art.sy, and Stackbuilders.
Juan Felipe Arango

Juan Felipe Arango

Web Developer

Passionate Web Developer with a strong sense of design concepts and UX, he holds a degree in System Engineering from EAFIT University and also a Minor degree in Design. Rails and JS lover, Juan Felipe loves to work on both (front-end and back end) sides of a project and also serve as a bridge between design teams and development teams. In free time he can be found trying to improve some development process, learn something new or exercising.
Oscar Rendon

Oscar Rendon

Engineer

Experienced Software Engineer, operating on the entire software life cycle, from conception to product release. Solid background in software design and software architecture. Oscar worked with C#/.NET stack, but now with Ruby and Elixir/Erlang. He loves exploring new languages, and as such, Oscar is also versed in Clojure, Elixir/Erlang (and Golang). He also co-organizer of Ruby Medellin meetup, Rails Girls workshops, and RubyConfCo conference.
Daniel Gomez

Daniel Gomez

Android Developer

As lead mobile engineer, Daniel oversees both the product roadmap on all mobile devices but also works in the trenches with my team developing primarily for Android. Previously Daniel has experience in projects on both the backend and client (doing native app development). He has worked at ISF de Colombia, MakinGIANTS, Fabrica Digital, Eafit University -- where he also did my undergraduate studies in Systems and Computer Engineering.
Santiago Bustamante

Santiago Bustamante

iOS Developer

Santiago Bustamante is an engineer who absolutely loves all new technologies (except Microsoft). With several years of experience developing native iOS games and applications both in academic and professional projects, he has experience developing REST APIs for communicating with the client and the server. Santiago has participated in multiple projects and have significant experience personally and professionally working both individually and on a team.
Justin Chung

Justin Chung

Consulting UX/UI Designer

Justin has extensive experience in designing various forms of visual communication and UX/UI, helping small to medium sized agencies, startups, and inspired individuals. He also has a solid background in marketing and advertising, leading the strategic development of multiple fortune 500 clients such as AT&T, Cosmopolitan of Las Vegas, JPMorgan Chase and Toyota Motor Sales for their diversity market efforts.
Gloria Tesch

Gloria Tesch

Social Media Marketer

Gloria Tesch is a published author, model and advocate with a robust social media following. She published two novels at the age of thirteen, earning her the distinction of being the world’s youngest novelist. 'Maradonia and the Seven Bridges' and 'Maradonia and the Escape from the Underworld', set up a sweeping epic journey into a fantastical world of magic and power. By 15, she published her first five books.
Alexander Bisignano

Alexander Bisignano

Investor and Advisor

Alexander Bisignano is the Founder and CEO of Phosphorus, a computational genomics company. He also co-founded and exited Recombine for $85M. Alex is a seasoned computer programmer with experience developing complex web applications and providing high-end bioinformatic solutions for molecular genetic data. He advises Ovum Medical on business strategy, fundraising and investor relations.

TERMS

MedAnswers
Overview
PRICE PER SHARE
DEADLINE
Jan. 25, 2018 at 7:59 AM UTC
VALUATION
Breakdown
MIN INVESTMENT
MAX INVESTMENT
00
OFFERING TYPE
Equity
ASSET TYPE

Maximum Number of Shares Offered subject to adjustment for bonus shares

Most Recent Fiscal Year-End

Prior Fiscal Year-End

Total Assets

$268,019

$85

Cash & Cash Equivalents

$266,519

$85

Accounts Receivable

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$350,000

$0

Revenue & Sales

$0

$0

Costs of Goods Sold

$0

$0

Taxes Paid

$0

$0

Net Income

-$176,882

$0

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000:

ALL UPDATES

‌
‌
‌
‌
‌
‌
‌
‌
‌

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign perk. Get rewarded for investing more into MedAnswers.
Owners bonus

Owner’s Bonus

Owner’s Bonus Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).

JOIN THE DISCUSSION

‌
‌
‌
‌

‌
‌
‌
‌

‌
‌
‌
‌

0/2500

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

WHY STARTENGINE?

REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

SECURE

Your info is your info. We take pride in keeping it that way!

DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS
Crowdfunding

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

MIN INVEST
VALUATION

Get To Know Us

Our Team

Careers

Blog

Let's Work Together

Raise Capital

Refer a Founder, earn $10k

Success Stories

Partnerships

Need Help

Contact Us

Help Center

Terms of Use

Privacy Policy

Disclaimer

Annual Reports

Form CRS

Terms of Use

Privacy Policy

Disclaimer

Annual Reports

Form CRS

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.
Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of investment opportunities:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (ATS) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies quoted on SE Secondary.

StartEngine Bulletin Board ("SE BB") is a bulletin board platform that advertises interest in shares of private companies that previously executed Reg CF or Reg A offerings. SE BB enables shareholders to communicate interest in potential sales of shares in private companies and investors to discover, review, and potentially invest in private companies. As a bulletin board platform, SE BB provides a venue for investors to access information about private company offerings and connect with potential sellers. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. While a security may be displayed on the bulletin board, these securities will be subject to certain restrictions which may prevent the ability to buy and sell these securities in a timely manner, if at all. Even if a security is qualified to be displayed on the bulletin board, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an offer to provide investment advice or service. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.

All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment.